(Q33618621)

English

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection (English)

1 reference

Europe PubMed Central

28 July 2017

author name string

R R Bartlett

1

1 reference

Europe PubMed Central

28 July 2017

M Dimitrijevic

2

1 reference

Europe PubMed Central

28 July 2017

T Mattar

3

1 reference

Europe PubMed Central

28 July 2017

T Zielinski

4

1 reference

Europe PubMed Central

28 July 2017

T Germann

5

1 reference

Europe PubMed Central

28 July 2017

E Rüde

6

1 reference

Europe PubMed Central

28 July 2017

G H Thoenes

7

1 reference

Europe PubMed Central

28 July 2017

C C Küchle

8

1 reference

Europe PubMed Central

28 July 2017

H U Schorlemmer

9

1 reference

Europe PubMed Central

28 July 2017

E Bremer

10

1 reference

Europe PubMed Central

28 July 2017

publication date

1 January 1991

1 reference

Europe PubMed Central

28 July 2017

Agents and Actions

1 reference

Europe PubMed Central

28 July 2017

32

1 reference

Europe PubMed Central

28 July 2017

10-21

1 reference

Europe PubMed Central

28 July 2017

1-2

1 reference

Europe PubMed Central

28 July 2017

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides

1 reference

https://api.crossref.org/works/10.1007%2FBF01983301

21 January 2018

Some studies on the release of histamine from mast cells stimulated with polylysine

1 reference

https://api.crossref.org/works/10.1007%2FBF01983301

21 January 2018

B-cell stimulatory factor-1/interleukin 4.

1 reference

https://api.crossref.org/works/10.1007%2FBF01983301

21 January 2018

The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation

1 reference

https://api.crossref.org/works/10.1007%2FBF01983301

21 January 2018

Binding of G-CSF, GM-CSF, tumor necrosis factor-alpha, and gamma-interferon to cell surface receptors on human myeloid leukemia cells triggers rapid tyrosine and serine phosphorylation of a 75-Kd protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A spontaneous rheumatoid arthritis-like disease in MRL/l mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etiopathogenesis of Murine SLE1

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-3-induced activation of protein kinases in the mast cell/megakaryocyte R6-XE.4 line

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The induction of organ-specific antibodies during the graft-vs.-host reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant murine IL-3 fails to stimulate T or B lymphopoiesis in vivo, but enhances immune responses to T cell-dependent antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth factor receptor tyrosine kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of T cell activation by leukotriene B4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assay of growth factor-stimulated tyrosine kinases using synthetic peptide substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of leflunomide on glomerulonephritis induced by antibasement membrane antibody in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin A inhibits autoimmune experimental tubulointerstitial nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor and related molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-1 induces rapid phosphorylation of the IL-1 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential reactivity of isolated mast cells from the rat and guinea pig.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-3 supports growth of mouse pre-B-cell clones in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3

1 reference

https://pubmed.ncbi.nlm.nih.gov/2058454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01983301

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33618621&oldid=1606553053"